Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM vs PRALSETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POTASSIUM vs PRALSETINIB: Safety Overview

Metric POTASSIUM PRALSETINIB
Total FAERS Reports 11,986 1,419
Deaths Reported 2,094 226
Death Rate 17.5% 15.9%
Hospitalizations 5,157 431
Average Patient Age 61.6 yrs 61.9 yrs
% Female Patients 56.0% 56.6%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 4, 2020
Manufacturer XLCare Pharmaceuticals, Inc. Genentech, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription